Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents

被引：69
|
作者：
Doherty, AM [1 ]
机构：
[1] Inst Rech Jouveinal Parke Davis, F-94265 Fresnes, France
来源：
CURRENT OPINION IN CHEMICAL BIOLOGY | 1999年 / 3卷 / 04期
关键词：
D O I：
10.1016/S1367-5931(99)80068-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Preclinical and clinical studies of phosphodiesterase 4 inhibitors have shown that these agents may find utility in a wide range of inflammatory disorders, including asthma, chronic obstructive pulmonary disease, atopic dermatitis, rheumatoid arthritis, multiple sclerosis and various neurological disorders. The future of this class of drugs will depend upon the ability to demonstrate a reasonable safety margin against emesis and other typical phosphodieserase (PDE4) side effects, as well as in identification of the inflammatory disorder(s) most relevant to PDE4 inhibition.
引用
收藏
页码：466 / 473
页数：8
相关论文
共 50 条
  • [31] Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents
    Penning, TD
    CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (03) : 163 - 179
  • [32] A new therapeutic approach in Parkinson's disease: Some novel quinazoline derivatives as dual selective phosphodiesterase 1 inhibitors and anti-inflammatory agents
    Laddha, Sachin S.
    Bhatnagar, Satyendra P.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (19) : 6796 - 6802
  • [33] Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti-inflammatory/Antioxidant Agents
    Cichero, Elena
    Rapetti, Federica
    Lusardi, Matteo
    Scarano, Naomi
    Alfei, Silvana
    Altieri, Paola
    Garibaldi, Silvano
    Ameri, Pietro
    Signorello, Maria Grazia
    Brullo, Chiara
    CHEMMEDCHEM, 2023, 18 (09)
  • [34] ANTI-INFLAMMATORY AGENTS
    RENNIE, JAN
    PRACTITIONER, 1981, 225 (1360) : 1387 - &
  • [35] Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors
    Oger, S
    Méhats, C
    Barnette, MS
    Ferré, F
    Cabrol, D
    Leroy, MJ
    BIOLOGY OF REPRODUCTION, 2004, 70 (02) : 458 - 464
  • [36] DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity
    Hunt, David W. C.
    Ivanova, Iordanka A.
    Dagnino, Lina
    TISSUE BARRIERS, 2020, 8 (03):
  • [37] Phospholipase A2 inhibitors as potential anti-inflammatory agents
    Meyer, MC
    Rastogi, P
    Beckett, CS
    McHowat, J
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (10) : 1301 - 1312
  • [38] Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation
    Zheng, Xiao-Fang
    Chen, Dan-Dan
    Zhu, Xiao-Ling
    Le Grange, Jehane Michael
    Zhou, Lu-Qian
    Zhang, Jin-Nong
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (04):
  • [39] Nonsteroidal anti-inflammatory drugs as potential ecto-nucleotide phosphodiesterase inhibitors
    Tasneem, Shumaila
    Saleem, Muhammad
    Saeed, Sheikh Arshad
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 56
  • [40] Selective phosphodiesterase inhibitors as new anti-inflammatory compounds for the treatment of airway diseases
    Lagente, V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 59 - 59
12345